PROMAFUN CRIO and DataSenseLabs Form Strategic Partnership to Strengthen Early-Stage Feasibility Assessment

PROMAFUN CRIO and DataSenseLabs, a specialist company in AI-enabled risk assessment, digital biomarkers, and predictive modelling. This collaboration represents an important step in our mission to help biotech, medtech, and diagnostics innovators make robust, evidence-based decisions at the earliest stages of developments.

DataSenseLabs brings advanced expertise in transforming complex biological, clinical, and experimental data into actionable insights using artificial intelligence and computational modelling. Their platforms are designed to identify hidden risk patterns, predict development bottlenecks, and support earlier, more confident go/no-go decisions.

PROMAFUN CRIO specialises in guiding early-and mid-stage innovators through scientific feasibility evaluation, funding strategy and CRO preparedness, ensuring that concepts are genuinely development-ready before significant time and capital are committed. Our work focuses on reducing uncertainty at the interface between innovation and execution.

By combining PROMAFUN CRIO’s strategic and experimental expertise with DataSenseLabs’ AI-driven analytics, this partnership creates a complementary ecosystem that supports clients across the full early development trajectory, including:
– Scientific and technical feasibility
– AI-driven modelling, risk prediction, and digital biomarkers
– Preclinical validation and study design strategies
– Regulatory-aligned workflows and decision frameworks
-Smooth transition into GLP studies and early clinical execution

Together, we enable faster, deeper, and more reliable feasibility assessments by integrating computational intelligence, experimental insight, and strategic development planning. This integrated approach allows innovators to move from idea to evidence to development with greater clarity, reduced risk, and stronger alignment with regulatory and funding expectations.

PROMAFUN CRIO and DataSenseLabs share a common vision: empowering innovators to make better decisions earlier, avoid costly downstream failures, and accelerate the development of impactful technologies.

We look forward to supporting a growing number of companies in translating strong scientific ideas into successful, executable development programs.